Global Reach Bracco operates in over 110 markets with a heavy international revenue share (89%), indicating strong global penetration and potential to leverage cross-border sales teams for new imaging contrast products and related devices.

Imaging Leadership As a leader in diagnostic imaging across X-Ray/CT, MRI, CEUS, and Nuclear Medicine, Bracco presents abundant opportunities to cross-sell advanced contrast agents, administration systems, and complementary imaging solutions to existing radiology customers.

R&D Focus With about 10% of revenue invested in R&D for imaging diagnostics and medical devices, Bracco is likely receptive to collaborative development, pilot programs, and early-access partnerships for innovative contrast agents or imaging workflows.

Sustainability EcoVadis Platinum Medal and ongoing sustainability initiatives position Bracco as a partner of choice for customers prioritizing responsible supply chains, opening doors for sustainability-focused proposals, audits, and compliant procurement solutions.

Strategic Partnerships Recent collaborations and product launches (VueJect injector, BubbleGen kit, Latin America market expansion) signal openness to new alliances and channel agreements, ideal for distribution partnerships, regional expansion deals, and co-marketing initiatives.